Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v10-EN
Language English English
Date Updated 2018-07-31 2018-07-31
Drug Identification Number 01997572 01997572
Brand name DANTRIUM INTRAVENOUS DANTRIUM INTRAVENOUS
Common or Proper name Dantrolene Sodium for Injection Dantrolene Sodium for Injection
Company Name ENDO PAR INNOVATION COMPANY, LLC ENDO PAR INNOVATION COMPANY, LLC
Ingredients DANTROLENE SODIUM DANTROLENE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Box containing 6x20mg Vial Box containing 6x20mg Vial
ATC code M03CA M03CA
ATC description MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-03-22 2018-03-22
Estimated end date 2018-07-15 2018-07-15
Actual end date 2018-07-30 2018-07-30
Shortage status Resolved Resolved
Company comments
Health Canada comments